Clinical Trials
9 trialsNCT02085655 2021-03-15
PEG-ASP+Gemox Regimen and Thalidomide for NK/T Lymphoma
Sun Yat-sen University
Phase 3 Unknown
NCT01554852 2018-06-11
Myeloma XI
University of Leeds
Phase 3 Unknown
NCT02248428 2017-09-06
CTd
Jinling Hospital, China
Phase 3 Unknown
NCT03016000 2017-07-28
Thalidomide Maintenance Treatment in DLBCL
Nanfang Hospital, Southern Medical University
Phase 3 Unknown
NCT02748772 2016-04-22
Application of Two Anti-angiogenesis Drugs Combined With Chemotherapy in Advanced Colorectal Cancer Under the Background of Precision Medical
The First People's Hospital of Hefei
Phase 3 Unknown
NCT00028886 2013-09-17
Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma
National Cancer Institute (NCI)
Phase 3 Unknown
NCT01134484 2012-07-20
VELCADE-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone (TD) Incorporated Into Double Autotransplantation for Untreated Multiple Myeloma (MM)
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase 3 Unknown
NCT01532856 2012-02-15
Iberoamerican Protocol With Thalidomide in Patients With Symptomatic Newly Diagnosed Multiple Myeloma Over 65 Years
Grupo de Estudos Multicentricos em Onco-Hematologia
Phase 3 Unknown
NCT00921531 2011-04-19
Adjuvant Therapy With Thalidomide for Chemoembolization in Advanced Hepatocellular Carcinoma
Fudan University
Phase 3 Unknown